Jennifer B Nadelmann (Jennifer Nadelmann)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Diabetic Retinopathy

Top Venues

Clinical ophthalmology (Auckland, N.Z.)

The British journal of ophthalmology

Eye (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer B Nadelmann, Yafeng Li, Brendan McGeehan, Yinxi Yu, Brian L VanderBeek
Systemic disease associations with angioid streaks in a large healthcare claims database. Eye (London, England) (2022)
Jennifer B Nadelmann, Vatinee Y Bunya, Gui-Shuang Ying, Peiying Hua, Mina Massaro-Giordano
Effect of Autologous Platelet-Rich Plasma Drops in the Treatment of Ocular Surface Disease. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)
Jennifer B Nadelmann, Vatinee Y Bunya, Gui-Shuang Ying, Peiying Hua, Mina Massaro-Giordano
Effect of Autologous Platelet-Rich Plasma Drops in the Treatment of Ocular Surface Disease. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)
Carley M Bogan, Jessica V Kaczmarek, Janene M Pierce, Sheau-Chiann Chen, Kelli L Boyd, Marion W Calcutt, Thomas M Bridges, Craig W Lindsley, Jennifer B Nadelmann, Albert Liao, Terry Hsieh, David H Abramson, Jasmine H Francis, Debra L Friedman, Ann Richmond, Anthony B Daniels
Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. The British journal of ophthalmology (2021)
Jennifer B Nadelmann, Jasmine H Francis, Scott E Brodie, Engjel Muca, David H Abramson
Is intravitreal topotecan toxic to retinal function? The British journal of ophthalmology 105 (7) (2020)